A detailed history of Dana Investment Advisors, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 1,937 shares of VRTX stock, worth $973,245. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,937
Previous 1,937 -0.0%
Holding current value
$973,245
Previous $907,000 -0.0%
% of portfolio
0.03%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $105,273 - $130,122
-268 Reduced 12.15%
1,937 $907,000
Q4 2023

Feb 07, 2024

BUY
$343.0 - $410.68 $756,315 - $905,549
2,205 New
2,205 $897,000
Q1 2021

May 13, 2021

SELL
$207.02 - $241.31 $1.69 Million - $1.97 Million
-8,149 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$207.01 - $276.09 $784,981 - $1.05 Million
-3,792 Reduced 31.76%
8,149 $1.93 Million
Q3 2020

Nov 10, 2020

SELL
$255.65 - $303.1 $4.57 Million - $5.42 Million
-17,886 Reduced 59.97%
11,941 $3.25 Million
Q2 2020

Aug 11, 2020

BUY
$225.48 - $295.8 $3.41 Million - $4.47 Million
15,114 Added 102.73%
29,827 $8.66 Million
Q1 2020

May 13, 2020

BUY
$199.77 - $247.81 $288,667 - $358,085
1,445 Added 10.89%
14,713 $3.5 Million
Q4 2019

Feb 11, 2020

SELL
$166.71 - $223.91 $165,209 - $221,894
-991 Reduced 6.95%
13,268 $2.91 Million
Q3 2019

Nov 12, 2019

BUY
$166.23 - $187.09 $527,780 - $594,010
3,175 Added 28.64%
14,259 $2.42 Million
Q2 2019

Aug 13, 2019

SELL
$164.61 - $190.37 $1.07 Million - $1.23 Million
-6,487 Reduced 36.92%
11,084 $2.03 Million
Q1 2019

May 15, 2019

SELL
$163.73 - $194.7 $799,984 - $951,304
-4,886 Reduced 21.76%
17,571 $3.23 Million
Q4 2018

Feb 14, 2019

SELL
$151.91 - $192.21 $376,129 - $475,911
-2,476 Reduced 9.93%
22,457 $3.72 Million
Q3 2018

Nov 14, 2018

BUY
$167.73 - $192.74 $4.18 Million - $4.81 Million
24,933 New
24,933 $4.81 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Dana Investment Advisors, Inc. Portfolio

Follow Dana Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.